The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// STATE LEGISLATION TRACKER

Minnesota HF 3718: Veterinary medicine and veterinary technology practice provisions modified.

โš–๏ธ NEUTRAL for peptide users ๐Ÿ‘ค NONE user impact ๐Ÿ“œ Status: Signed
State
Minnesota
Bill
HF 3718
Session
2025-2026
Filed
2026-02-25
Read the bill
OpenStates โ†’
Last reviewed
2026-10-02

Plain-English Summary

Minnesota HF3718 updates veterinary medicine and veterinary technology rules, including veterinary telemedicine, drug-related definitions, and veterinary practice oversight. It appears to affect animal care only, so it has no direct impact on human peptide access, compounded peptides, off-label prescribing, NPs, naturopaths, or peptide telehealth clinics.

Key Points

  • No direct change to human peptide prescribing or use
  • Does not appear to affect NP or naturopath scope
  • Does not appear to change human 503A or 503B compounding
  • Veterinary drug and telemedicine rules may change for animal care
  • Peptide users should not treat this as a human prescribing bill

What to Watch For

i
Note Any drug-control provisions appear tied to veterinary practice, not human peptide clinics.
i
Note Veterinary telemedicine updates may matter only for animal patients and veterinarians.
i
Note No clear impact on prescription monitoring for human peptide users from the title and subjects.

Where the Bill Stands

The bill completed the legislative process, was approved by the governor on April 29, 2026, and has an effective date of July 1, 2026.
ยท Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 ยท enriched via codex gpt-5.5
Source: OpenStates v3 API ยท View official bill ยท โ† back to all laws